↓ Skip to main content

395 著明な高フェリチン血症を来たした3症例の末梢血中サイトカイン濃度の推移(膠原病と類縁疾患(5), 第55回日本アレルギー学会秋季学術大会)

Overview of attention for article published in Arerugī Allergy, September 2005
Altmetric Badge

Mentioned by

twitter
2 X users
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
395 著明な高フェリチン血症を来たした3症例の末梢血中サイトカイン濃度の推移(膠原病と類縁疾患(5), 第55回日本アレルギー学会秋季学術大会)
Published in
Arerugī Allergy, September 2005
DOI 10.15036/arerugi.54.1105_3
Authors

萩野 昇, 猪熊 茂子, 坪井 洋人, 長島 千佳, 古木名 和枝, 田中 良明, 瀬戸口 京吾, 河野 肇

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 September 2020.
All research outputs
#17,295,853
of 25,385,509 outputs
Outputs from Arerugī Allergy
#206
of 484 outputs
Outputs of similar age
#61,481
of 69,137 outputs
Outputs of similar age from Arerugī Allergy
#1
of 2 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 484 research outputs from this source. They receive a mean Attention Score of 4.4. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 69,137 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 5th percentile – i.e., 5% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them